Barclays PLC rose 2.6% during the afternoon session to $7.83 per share. As reported by Reuters: "LONDON, Nov 29 ( Reuters ) - The cancer affecting Barclays Chief Executive C.S. Venkatakrishnan was detected early and is "very localised", meaning doctors are optimistic, he told a conference on Tuesday. Barclays said on Monday that Venkatakrishnan would undergo 12-16 weeks of treatment in New ..." You can read more about it here. For those of you thinking about investing in the stock, here is a brief look at the company's fundamentals.
Barclays PLC, through its subsidiaries, provides various financial products and services in the United Kingdom, Europe, the Americas, Africa, the Middle East, and Asia. The company belongs to the Financial Services sector, which has an average price to earnings (P/E) ratio of 13.34 and an average price to book (P/B) ratio of 1.95. In contrast, Barclays PLC has a trailing 12 month P/E ratio of 5.4 and a P/B ratio of 0.5.
Barclays PLC has moved -22.9% over the last year compared to -13.2% for the S&P 500 -- a difference of -9.7%. Barclays PLC has a 52 week high of $12.2 and a 52 week low of $5.89.